Figures & data
Figure 1. MinoCard.
(A) Design of the cartridge. 1 – blister position, 2 – socket for a sample container, 3,5,6,8 – washing chambers (10 μl each), 4 – optionally washing or lysis chamber (20 μl), 7 – amplification chamber (50 μl), 9 – (optionally) hybridization chamber, 10 – waste chamber. T1–T4: positions of Peltier elements (on the external instrument). Ch1: 1.4 mm-wide channel, Ch2 – 0.4 mm-wide channel. (B) Attachment of a sample container (a syringe or a special container) to the socket.
![Figure 1. MinoCard.(A) Design of the cartridge. 1 – blister position, 2 – socket for a sample container, 3,5,6,8 – washing chambers (10 μl each), 4 – optionally washing or lysis chamber (20 μl), 7 – amplification chamber (50 μl), 9 – (optionally) hybridization chamber, 10 – waste chamber. T1–T4: positions of Peltier elements (on the external instrument). Ch1: 1.4 mm-wide channel, Ch2 – 0.4 mm-wide channel. (B) Attachment of a sample container (a syringe or a special container) to the socket.](/cms/asset/7ae6f748-3aed-46ee-b76b-65f623b09326/ifso_a_12363958_f0001.jpg)
Figure 2. MinoLyzer.
(A) Schematic diagram of the modules of the MinoLyzer with the microfluidic cartridge. (B) The functional prototype of the instrument.
![Figure 2. MinoLyzer.(A) Schematic diagram of the modules of the MinoLyzer with the microfluidic cartridge. (B) The functional prototype of the instrument.](/cms/asset/e2d28d5c-7eab-40d9-86df-5d9102a861ae/ifso_a_12363958_f0002.jpg)
Figure 3. Detection of S. enteritidis via loop-mediated isothermal amplification performed after the immunomagnetic pathogen isolation.
(A) On-chip real-time optical detection. (B) Reference samples processed in LightCycler®.
![Figure 3. Detection of S. enteritidis via loop-mediated isothermal amplification performed after the immunomagnetic pathogen isolation.(A) On-chip real-time optical detection. (B) Reference samples processed in LightCycler®.](/cms/asset/a78aeccb-a42c-4010-8aa5-5420397b9086/ifso_a_12363958_f0003.jpg)
Figure 4. Detection of E. coli DNA after the immunomagnetic preconcentration, lysis and PCR on the chip.
(A) On-chip real-time optical detection. (B) Off-chip analysis of PCR products in gel electrophoresis.
S1-S3: Sample replicates; NC: Negative control (no template); PC: Positive control (0.5 ng E. coli DNA).
![Figure 4. Detection of E. coli DNA after the immunomagnetic preconcentration, lysis and PCR on the chip.(A) On-chip real-time optical detection. (B) Off-chip analysis of PCR products in gel electrophoresis.S1-S3: Sample replicates; NC: Negative control (no template); PC: Positive control (0.5 ng E. coli DNA).](/cms/asset/e87119a2-562b-42f4-9966-a5f1c340fe95/ifso_a_12363958_f0004.jpg)
Figure 5. Generation of the pH gradient (referred to the color scale left) for the DNA binding, washing and elution in the valve-free cartridge.
![Figure 5. Generation of the pH gradient (referred to the color scale left) for the DNA binding, washing and elution in the valve-free cartridge.](/cms/asset/96c6b43a-840c-4a8e-84b3-d13bc10df66a/ifso_a_12363958_f0005.jpg)
Figure 6. Detection of E. coli in the full assay (bacteria preconcentration, lysis, DNA purification and PCR) on the chip.
(A) On-chip real-time optical detection. (B) Off-chip analysis of PCR products in gel electrophoresis.
*Expected position of specific PCR product (152 bp).
F1–F3: Sample replicates; NC: Negative control (no template); PC: Positive PCR control in thermocycler (5 ng E. coli DNA).
![Figure 6. Detection of E. coli in the full assay (bacteria preconcentration, lysis, DNA purification and PCR) on the chip.(A) On-chip real-time optical detection. (B) Off-chip analysis of PCR products in gel electrophoresis.*Expected position of specific PCR product (152 bp).F1–F3: Sample replicates; NC: Negative control (no template); PC: Positive PCR control in thermocycler (5 ng E. coli DNA).](/cms/asset/8060dba9-5a74-45a3-b03f-00d7832507d4/ifso_a_12363958_f0006.jpg)